Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Invested Capital (2019 - 2025)

Pulmonx (LUNG) has disclosed Invested Capital for 7 consecutive years, with $97.2 million as the latest value for Q3 2025.

  • Quarterly Invested Capital fell 25.92% to $97.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $97.2 million through Sep 2025, down 25.92% year-over-year, with the annual reading at $122.7 million for FY2024, 20.92% down from the prior year.
  • Invested Capital for Q3 2025 was $97.2 million at Pulmonx, down from $106.2 million in the prior quarter.
  • The five-year high for Invested Capital was $233.5 million in Q1 2021, with the low at $17.4 million in Q3 2021.
  • Average Invested Capital over 5 years is $149.0 million, with a median of $155.2 million recorded in 2023.
  • The sharpest move saw Invested Capital skyrocketed 940.05% in 2022, then tumbled 79.41% in 2023.
  • Over 5 years, Invested Capital stood at $210.1 million in 2021, then decreased by 18.67% to $170.9 million in 2022, then fell by 9.2% to $155.2 million in 2023, then decreased by 20.92% to $122.7 million in 2024, then dropped by 20.82% to $97.2 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $97.2 million, $106.2 million, and $114.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.